Event Report 2022
-
ICH Project
The 4th ICH Forum: ICH Efficacy Guideline Update
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2022" was held
-
Patient Cooperation Committee
The 40th JPMA Patient Group Seminar" was held.
Thinking Together and Taking Steps Forward, Patient and Public Involvement in Healthcare (PPI) -
International Affairs Committee
The 3rd Japan-Vietnam Joint Symposium" was held
-
APAC Project
The 1st APAC e-labeling Regulators Workshop" was held.
-
Drug Evaluation Committee
Assembly of the Drug Evaluation Committee for FY2022
Paving the way to the future of healthcare through Digital Transformation! ～From Disease to Pre-disease and Well being -
International Affairs Committee
Held "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)
-
Secretariat
The 21st JPMA Forum" was held.
-
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
International Affairs Committee
The "Regular Meeting with the French Association of the Pharmaceutical Industry (Leem)" was held
-
International Affairs Committee
The "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)" was held.
-
International Affairs Committee
Special Session at the 9th Nikkei-FT Infectious Diseases Conference
Toward the Creation of a Drug Discovery Ecosystem in the Field of Infectious Diseases - Focusing on Collaboration among Industry, Government, and Academia -
ICH Project
ICH Incheon Meeting" was held
-
International Affairs Committee
JPMA Media Forum" Held
-Antimicrobial Resistance (AMR) Promotion Month -
The Office of Pharmaceutical Industry Research
The Economics of Invention," a book written by Director Nagaoka of the Policy Research Institute, won the 65th Nikkei Economic Book Award.
-
International Affairs Committee
The 10th Japan-Taiwan Pharmaceutical Exchange Conference" was held
-
Public Affairs Committee
The 38th Public Relations Seminar
-ESG Management, Information Disclosure and Relationship with Society -
Biopharmaceutical Committee
Report on the BioJapan 2022
Ceremony, Keynote Speech, and Biopharmaceutical Committee Seminar -
Public Affairs Committee
JPMA President to Speak at Special Session at Nikkei Cross Health EXPO 2022
Directions and Challenges for the Transformation of Pharmaceutical Companies in the Era of Innovation Ecosystems -
Code Compliance Committee
Meeting of Code Administration Managers and Practitioners for FY2022
-
Regulatory Affairs Committee
The 12th Annual Meeting of the Regulatory Science Society of Japan" was held
Current status and future of human resource development for regulatory science -
Public Affairs Committee
JPMA Presidents Press Conference
Current status and recognition of issues surrounding the pharmaceutical industry and basic framework for their solution -
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Aiming for Appropriate Use of Pharmaceuticals -To Deliver Reliable Drug Information to Patients -
International Affairs Committee
The 2nd Japan-Malaysia Symposium" will be held
-
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Considering the various values that pharmaceuticals can bring - For the rich everyday life that patients and their families desire -
International Affairs Committee
Held "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)
-
ICH Project
ICH Athens Meeting Held in Hybrid Format for the First Time
-
Drug Evaluation Committee
Joint Assembly of Drug Evaluation Committee and Regulatory Affairs Committee for FY 2022
-
International Affairs Committee
JPMA Media Forum" Held
～The current state of drug resistance (AMR) and the need for new antimicrobial agents to address this challenge -
Public Affairs Committee
The 37th Public Relations Seminar
-News Explanation, News Program Production Today -
APAC Project
The 11th APAC (Asian Pharmaceutical Association Collaboration Conference)
-Mission: Bringing Innovative Medicines to the People of Asia Promptly
Theme: "APAC: Building a Platform to Deliver Valuable Innovations to the People of Asia for the Next Decade -
Review Board of Ethical Drug Product Information Brochure
Workshop for Persons Responsible for Product Information Overview Management and Practice Management in FY2021" was held.
-
Pharmaceutical Industrial Policy Committee
Information Meeting on "Cost-Effectiveness Evaluation System
-
Public Affairs Committee
The 33rd JPMA Policy Seminar
Toward the Creation of Innovative New Drugs from Japan: Building a Healthcare Ecosystem for Continuous Innovation -
Public Affairs Committee
The 33rd JPMA Policy Seminar
Toward the Creation of Innovative New Drugs from Japan: Building a Healthcare Ecosystem for Continuous Innovation -
ICH Project
Report on "Briefing Session on eCTD v4.0 (ICH M8) Notification Revision and Start of Implementation
-
Code Compliance Committee
2021 Meeting of Compliance Managers and Practitioners in Charge of Compliance Management
-
Intellectual Property Committee
The "2022 Life Science Intellectual Property Forum" was held.
-COVID-19 Pandemic: Challenges and Prospects for Innovation Ecosystems -COVID-19 Pandemic: Challenges and Prospects for Solutions -
International Affairs Committee
Regular meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)" was held
-
International Affairs Committee
The 8th Japan-Thailand Joint Symposium" was held
-
Public Affairs Committee
JPMA Presidents Press Conference
Toward Full-Scale Discussion of Pharmaceutical Industry Policies: Current Situation and Recognition of Issues